Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
RESEARCH TOOLSreports
Cognition Therapeutics (CGTX) Stock Price & Analysis
63 Followers
CGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.90 - $3.49
Previous Close$2
Volume114.82K
Average Volume (3M)202.15K
Market Cap
$78.00M
Enterprise Value$48.77M
Total Cash (Recent Filing)$29.92M
Total Debt (Recent Filing)$694.00K
Price to Earnings (P/E)-2.3
Beta0.86
Next Earnings
May 08, 2024EPS Estimate
-$0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.86
Shares Outstanding39,000,152
10 Day Avg. Volume129,187
30 Day Avg. Volume202,154
Standard Deviation0.28
R-Squared0.09
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)2.96
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.97
Forecast
1Y Price Target
$7.00Price Target Upside251.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cognition Therapeutics News
Ownership Overview
49.20% Insiders
2.47% Mutual Funds
2.50% Other Institutional Investors
45.83% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CGTX FAQ
What was Cognition Therapeutics’s price range in the past 12 months?
Cognition Therapeutics lowest stock price was $0.90 and its highest was $3.49 in the past 12 months.
What is Cognition Therapeutics’s market cap?
Currently, no data Available
When is Cognition Therapeutics’s upcoming earnings report date?
Cognition Therapeutics’s upcoming earnings report date is May 08, 2024 which is in 13 days.
How were Cognition Therapeutics’s earnings last quarter?
Cognition Therapeutics released its earnings results on Mar 26, 2024. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.32 by $0.05.
Is Cognition Therapeutics overvalued?
According to Wall Street analysts Cognition Therapeutics’s price is currently Undervalued.
Does Cognition Therapeutics pay dividends?
Cognition Therapeutics does not currently pay dividends.
What is Cognition Therapeutics’s EPS estimate?
Cognition Therapeutics’s EPS estimate is -$0.25.
How many shares outstanding does Cognition Therapeutics have?
Cognition Therapeutics has 39,000,153 shares outstanding.
What happened to Cognition Therapeutics’s price movement after its last earnings report?
Cognition Therapeutics reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.32. Following the earnings report the stock price went up 0.549%.
Which hedge fund is a major shareholder of Cognition Therapeutics?
Among the largest hedge funds holding Cognition Therapeutics’s share is Carlson Capital LP. It holds Cognition Therapeutics’s shares valued at 440K.
---
Cognition Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (251.76% Upside)
$7.00 (251.76% Upside)
Hedge Fund Trend
Decreased
By 52.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $10.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.27%
12-Months-Change
Fundamentals
Return on Equity
-79.69%
Trailing 12-Months
Asset Growth
-30.27%
Trailing 12-Months
Company Description
Cognition Therapeutics
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
---
CGTX Earnings Call
Q4 2024
0:00 / 0:00
---
CGTX Stock 12 Months Forecast
Average Price Target
$7.00
▲(251.76% Upside)
Technical Analysis
Best Analysts Covering CGTX
1 Year
1 Year Success Rate
6/13 ratings generated profit
1 Year Average Return
-15.52%
reiterated a buy rating 29 days ago
Copying Mayank Mamtani's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of -15.52% per trade.
---